Business

argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

October 23, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, October 30, 2025 at 1:30 PM CET (8:30 AM ET) to discuss its third quarter 2025 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at arg

articleArgenx SeOctober 23, 20251/company/argenx-se/news/argenx-to-report-third-quarter-2025-financial-results-and-business-update-on-october-30-2025
argenx to Report Third Quarter 2025 Financial Results and Business Update on October 30, 2025

About this update from Argenx Se

[{"type":"image","alt":"argenx SE","displaySize":"","headline":null,"caption":"argenx SE","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":97,"url":"https://media.zenfs.com/en/globenewswire.com/f35a3a919b58945aa6a1a93a9b760119"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_55.hEettGltaZ5cA.9xTw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f35a3a919b58945aa6a1a93a9b760119","width":300,"height":97}},"lazy":false},{"type":"text","content":"October 23, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, October 30, 2025 at 1:30 PM CET (8:30 AM ET) to discuss its third quarter 2025 financial results and provide a business update.","length":409,"tagName":"p"},{"type":"text","content":"A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation.","length":233,"tagName":"p"},{"type":"text","content":"Dial-in numbers:","length":16,"tagName":"p"},{"type":"text","content":"Belgium                32 800 50 201France                        33 800 943355Netherlands                31 20 795 1090United Kingdom        44 800 358 0970United States                1 888 415 4250Japan                        81 3 4578 9081Switzerland                41 43 210 11 32","length":891,"tagName":"p"},{"type":"text","content":"Use the access code 3810049 to join the call. Please dial in 15 minutes prior to the live call.","...

More updates from Argenx Se

autoimmune diseasesargenx